PZ Cussons plc : Perfect timing to aim a technical rebound
Entry price | Target | Stop-loss | Potential |
---|
GBX 303.3 |
GBX 0 |
GBX 299.7 |
-100% |
---|
PZ Cussons, manufacturer of personal healthcare products, shows relatively strong fundamentals and is coming back to attractive price.
However, analysts have revised slightly downward their earnings forecasts. With an EPS estimated at 15.96 cts GBP for this year and 17.83 cts GBP for the next year, PZ Cussons is currently paid 19 and 17.01 times the results.
The security follows a downward trend in the short term, under the GBp 316.2 resistance area. The stock is trading within a range between GBp 302.4 and GBp 316.2. The security is not likely to continue its downtrend because it is near to the strong GBp 302.4 and it is in oversold situation.
Therefore, the proximity of the GBp 302.4 support is an opportunity to take a long position in PZ Cussons. The first goal is a return in the GBp 316.2 resistance area, that is a potential of 4.3 %. In fact, the security has to cross this area in order to re-establish a bullish trend in the short term. A stop loss order can be placed under the support currently tested.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.